Weiss Multi-Strategy Advisers’s NxStage Medical Inc. NXTM Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-20,000	Closed	-$286K	–	531
2015 Q2	$286K	Buy	+20,000	New	+$339K	0.01%	403
2014 Q2	–	Sell	-10,000	Closed	-$127K	–	1031
2014 Q1	$127K	Sell	10,000 -15,000	-60%	-$196K	﹤0.01%	932
2013 Q4	$250K	Buy	25,000 +15,000	+150%	+$170K	0.01%	860
2013 Q3	$132K	Buy	+10,000	New	+$131K	﹤0.01%	879

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Weiss Multi-Strategy Advisers's NXTM Position: Q3 2017 in Review

Weiss Multi-Strategy Advisers sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 94,000 shares — an estimated $2.36M sold.

Weiss Multi-Strategy Advisers first reported a position in NXTM in Q2 2013 and held it in 17 quarters. The position peaked at $5.38M in Q4 2014. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

Weiss Multi-Strategy Advisers reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 94,000 NxStage Medical Inc. shares in Q3 2017, an estimated $2.36M.
Weiss Multi-Strategy Advisers first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 17 quarters.
Weiss Multi-Strategy Advisers's NxStage Medical Inc. position peaked at $5.38M in Q4 2014.
168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2017, filed 14 Nov 2017.